It is a company with a breakthrough therapy that wants to hack your DNA to battle cancer. Jim Cramer learns more from the CEO of Cellectis. » Subscribe to …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More